Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes. By Gina Kolata A single infusion ...
Ibrutinib may enhance lisocabtagene maraleucel efficacy in CLL patients with Richter transformation, showing an 83.3% response rate in a small case series. Four patients achieved minimal residual ...
T-cell immunoglobulin and mucin domain-containing protein-3 (Tim-3), an emerging immune checkpoint molecule, was found to critically regulate the pathogenesis of respiratory disorders, including ...
Immune thrombocytopenia (ITP) is an autoimmune disease, characterized by increased bleeding due to a reduced platelet count. The pathogenesis of ITP is very complex and involves autoantibody ...
In the mucosa, T cells and B cells of the immune system are essential for maintaining immune homeostasis by suppressing reactions to harmless antigens and upholding the integrity of intestinal mucosal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results